These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1733552)

  • 1. A clinical and pharmacological study of high-dose mitozolomide given in conjunction with autologous bone marrow rescue.
    McKeage M; Dady P; Clear M; MacDonald A
    Cancer Chemother Pharmacol; 1992; 29(3):201-6. PubMed ID: 1733552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase I clinical and pharmacological profile of dacarbazine with autologous bone marrow transplantation in patients with solid tumors.
    Adkins DR; Irvin R; Kuhn J; Boldt DH; Roodman GD; Salzman D; Freytes C; Von Hoff DD; LeMaistre CF
    Invest New Drugs; 1993; 11(2-3):169-79. PubMed ID: 8262729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between the pharmacokinetics and toxicity of mitozolomide.
    Kerr DJ; Slack JA; Secrett P; Stevens MF; Blackledge GR; Bradley C; Kaye SB
    Cancer Chemother Pharmacol; 1990; 25(5):352-4. PubMed ID: 2306796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I study of mitozolomide on a once daily for 5 days schedule.
    Schornagel JH; Simonetti G; Dubbelman R; ten Bokkel Huinink WW; McVie JG
    Cancer Chemother Pharmacol; 1990; 26(3):237-8. PubMed ID: 2357772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I clinical trial of mitozolomide.
    Newlands ES; Blackledge G; Slack JA; Goddard C; Brindley CJ; Holden L; Stevens MF
    Cancer Treat Rep; 1985; 69(7-8):801-5. PubMed ID: 4016790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancer.
    Lazarus HM; Herzig RH; Graham-Pole J; Wolff SN; Phillips GL; Strandjord S; Hurd D; Forman W; Gordon EM; Coccia P
    J Clin Oncol; 1983 Jun; 1(6):359-67. PubMed ID: 6366139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose cyclophosphamide or melphalan with escalating doses of mitoxantrone and autologous bone marrow transplantation for refractory solid tumors.
    Mulder PO; Sleijfer DT; Willemse PH; de Vries EG; Uges DR; Mulder NH
    Cancer Res; 1989 Aug; 49(16):4654-8. PubMed ID: 2545349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I trial of high-dose diaziquone and autologous bone marrow transplantation: an Illinois Cancer Council study.
    Stiff PJ; McKenzie RS; Potempa LD; Albain K; Koch D; Braud E; Bansal VK; Weidner MK; Lanzotti VJ; Chun HG
    J Clin Oncol; 1991 Aug; 9(8):1487-94. PubMed ID: 2072148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose i.v. thiotepa and cryopreserved autologous bone marrow transplantation for therapy of refractory cancer.
    Lazarus HM; Reed MD; Spitzer TR; Rabaa MS; Blumer JL
    Cancer Treat Rep; 1987; 71(7-8):689-95. PubMed ID: 3111687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered etoposide pharmacokinetics and time to engraftment in pediatric patients undergoing autologous bone marrow transplantation.
    Rodman JH; Murry DJ; Madden T; Santana VM
    J Clin Oncol; 1994 Nov; 12(11):2390-7. PubMed ID: 7964955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I trial of high-dose melphalan, high-dose etoposide and autologous bone marrow re-infusion in solid tumors: an Eastern Cooperative Oncology Group (ECOG) study.
    Lazarus HM; Gray R; Ciobanu N; Winter J; Weiner RS
    Bone Marrow Transplant; 1994 Sep; 14(3):443-8. PubMed ID: 7994270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I/pharmacokinetic reevaluation of thioTEPA.
    O'Dwyer PJ; LaCreta F; Engstrom PF; Peter R; Tartaglia L; Cole D; Litwin S; DeVito J; Poplack D; DeLap RJ
    Cancer Res; 1991 Jun; 51(12):3171-6. PubMed ID: 1710167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of high-dose etoposide after short-term infusion.
    Köhl P; Köppler H; Schmidt L; Fritsch HW; Holz J; Pflüger KH; Jungclas H
    Cancer Chemother Pharmacol; 1992; 29(4):316-20. PubMed ID: 1537079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and toxicity of two schedules of high dose epirubicin.
    Tjuljandin SA; Doig RG; Sobol MM; Watson DM; Sheridan WP; Morstyn G; Mihaly G; Green MD
    Cancer Res; 1990 Aug; 50(16):5095-101. PubMed ID: 2379173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase I study of bendamustine hydrochloride administered once every 3 weeks in patients with solid tumors.
    Rasschaert M; Schrijvers D; Van den Brande J; Dyck J; Bosmans J; Merkle K; Vermorken JB
    Anticancer Drugs; 2007 Jun; 18(5):587-95. PubMed ID: 17414628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I trial of temozolomide using an extended continuous oral schedule.
    Brock CS; Newlands ES; Wedge SR; Bower M; Evans H; Colquhoun I; Roddie M; Glaser M; Brampton MH; Rustin GJ
    Cancer Res; 1998 Oct; 58(19):4363-7. PubMed ID: 9766665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics of high-dose mitomycin C.
    Schilcher RB; Young JD; Ratanatharathorn V; Karanes C; Baker LH
    Cancer Chemother Pharmacol; 1984; 13(3):186-90. PubMed ID: 6386213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma pharmacokinetics of high-dose oral melphalan in patients treated with trialkylator chemotherapy and autologous bone marrow reinfusion.
    Choi KE; Ratain MJ; Williams SF; Golick JA; Beschorner JC; Fullem LJ; Bitran JD
    Cancer Res; 1989 Mar; 49(5):1318-21. PubMed ID: 2645050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I clinical trial of continuous infusion cyclopentenyl cytosine.
    Politi PM; Xie F; Dahut W; Ford H; Kelley JA; Bastian A; Setser A; Allegra CJ; Chen AP; Hamilton JM
    Cancer Chemother Pharmacol; 1995; 36(6):513-23. PubMed ID: 7554044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow support.
    Shea TC; Flaherty M; Elias A; Eder JP; Antman K; Begg C; Schnipper L; Frei E; Henner WD
    J Clin Oncol; 1989 May; 7(5):651-61. PubMed ID: 2651580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.